<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Shaligram SS</submitter><funding>National Institute of Neurological Disorders and Stroke</funding><funding>Michael Ryan Zodda Foundation</funding><funding>American Heart Association-American Stroke Association</funding><funding>Fondation Leducq</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>NHLBI NIH HHS</funding><funding>U.S. Department of Defense</funding><funding>NINDS NIH HHS</funding><funding>Barrow Neurological Foundation</funding><funding>American Health Assistance Foundation</funding><pagination>494-504</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9021325</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(3)</volume><pubmed_abstract>We have previously demonstrated that deletion of activin receptor-like kinase 1 (Alk1) or endoglin in a fraction of endothelial cells (ECs) induces brain arteriovenous malformations (bAVMs) in adult mice upon angiogenic stimulation. Here, we addressed three related questions: (1) could Alk1&lt;sup>-&lt;/sup> mutant bone marrow (BM)-derived ECs (BMDECs) cause bAVMs? (2) is Alk1&lt;sup>-&lt;/sup> ECs clonally expended during bAVM development? and (3) is the number of mutant ECs correlates to bAVM severity? For the first question, we transplanted BM from PdgfbiCreER;Alk1&lt;sup>2f/2f&lt;/sup> mice (EC-specific tamoxifen-inducible Cre with Alk1-floxed alleles) into wild-type mice, and then induced bAVMs by intra-brain injection of an adeno-associated viral vector expressing vascular endothelial growth factor an</pubmed_abstract><journal>Translational stroke research</journal><pubmed_title>Bone Marrow-Derived Alk1 Mutant Endothelial Cells and Clonally Expanded Somatic Alk1 Mutant Endothelial Cells Contribute to the Development of Brain Arteriovenous Malformations in Mice.</pubmed_title><pmcid>PMC9021325</pmcid><funding_grant_id>ATTRACT</funding_grant_id><funding_grant_id>HL122774</funding_grant_id><funding_grant_id>20POST35120371</funding_grant_id><funding_grant_id>PR161205</funding_grant_id><funding_grant_id>NS027713</funding_grant_id><funding_grant_id>NS112819</funding_grant_id><funding_grant_id>R01 HL122774</funding_grant_id><funding_grant_id>R01 NS112819</funding_grant_id><funding_grant_id>R01 NS027713</funding_grant_id><pubmed_authors>Shaligram SS</pubmed_authors><pubmed_authors>do Prado L</pubmed_authors><pubmed_authors>Ma L</pubmed_authors><pubmed_authors>Arnold T</pubmed_authors><pubmed_authors>Tang C</pubmed_authors><pubmed_authors>Li Q</pubmed_authors><pubmed_authors>Zhang R</pubmed_authors><pubmed_authors>Oh SP</pubmed_authors><pubmed_authors>Su H</pubmed_authors><pubmed_authors>Santander N</pubmed_authors><pubmed_authors>Luo M</pubmed_authors><pubmed_authors>Pan F</pubmed_authors><pubmed_authors>Pan P</pubmed_authors><pubmed_authors>Zhu W</pubmed_authors><pubmed_authors>Weiss M</pubmed_authors><pubmed_authors>Liang R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Bone Marrow-Derived Alk1 Mutant Endothelial Cells and Clonally Expanded Somatic Alk1 Mutant Endothelial Cells Contribute to the Development of Brain Arteriovenous Malformations in Mice.</name><description>We have previously demonstrated that deletion of activin receptor-like kinase 1 (Alk1) or endoglin in a fraction of endothelial cells (ECs) induces brain arteriovenous malformations (bAVMs) in adult mice upon angiogenic stimulation. Here, we addressed three related questions: (1) could Alk1&lt;sup>-&lt;/sup> mutant bone marrow (BM)-derived ECs (BMDECs) cause bAVMs? (2) is Alk1&lt;sup>-&lt;/sup> ECs clonally expended during bAVM development? and (3) is the number of mutant ECs correlates to bAVM severity? For the first question, we transplanted BM from PdgfbiCreER;Alk1&lt;sup>2f/2f&lt;/sup> mice (EC-specific tamoxifen-inducible Cre with Alk1-floxed alleles) into wild-type mice, and then induced bAVMs by intra-brain injection of an adeno-associated viral vector expressing vascular endothelial growth factor an</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2025-04-26T23:03:07.168Z</modification><creation>2025-04-06T17:24:33.159Z</creation></dates><accession>S-EPMC9021325</accession><cross_references><pubmed>34674144</pubmed><doi>10.1007/s12975-021-00955-9</doi></cross_references></HashMap>